Stockreport

Kadmon Announces Interim Phase 2 Data of KD025 in Chronic Graft-Versus-Host Disease

Kadmon Holdings, Inc.  (KDMN) 
Last kadmon holdings, inc. earnings: 3/5 04:14 pm Check Earnings Report
US:NYSE Investor Relations: investors.kadmon.com
PDF Overall Response Rate of 71%, with a Favorable Safety Profile Findings to be Presented and Webcast Today at 8:45 a.m. ET at Kadmon’s Research and [Read more]